299 related articles for article (PubMed ID: 10119188)
21. Impact of nosocomial infections on hospital costs.
Nightingale CH
Hosp Formul; 1993 Jan; 28 Suppl 1():51-4. PubMed ID: 10123840
[TBL] [Abstract][Full Text] [Related]
22. Appropriate but not cost effective ceftazidime use in a university hospital.
Colburn PA; Carver PA; Montgomery PA; Alaniz C; Chaffee BW; Amesbury BK
Hosp Pharm; 1989 Nov; 24(11):911-6, 928. PubMed ID: 10313376
[TBL] [Abstract][Full Text] [Related]
23. Aminoglycoside use monitored by clinical pharmaceutical services.
Barriere SL; Conte JE
Am J Hosp Pharm; 1979 Sep; 36(9):1209-11. PubMed ID: 495621
[TBL] [Abstract][Full Text] [Related]
24. Changes in antibiotic use, cost and consumption after an antibiotic restriction policy applied by infectious disease specialists.
Ozkurt Z; Erol S; Kadanali A; Ertek M; Ozden K; Tasyaran MA
Jpn J Infect Dis; 2005 Dec; 58(6):338-43. PubMed ID: 16377863
[TBL] [Abstract][Full Text] [Related]
25. Economic consequences of two drug-use control systems in a teaching hospital.
Clapham CE; Hepler CD; Reinders TP; Lehman ME; Pesko L
Am J Hosp Pharm; 1988 Nov; 45(11):2329-40. PubMed ID: 3228089
[TBL] [Abstract][Full Text] [Related]
26. A World Wide Web-based antimicrobial stewardship program improves efficiency, communication, and user satisfaction and reduces cost in a tertiary care pediatric medical center.
Agwu AL; Lee CK; Jain SK; Murray KL; Topolski J; Miller RE; Townsend T; Lehmann CU
Clin Infect Dis; 2008 Sep; 47(6):747-53. PubMed ID: 18680419
[TBL] [Abstract][Full Text] [Related]
27. Economic impact and clinical benefits of pharmacist involvement on surgical wards.
Ariano RE; Demianczuk RH; Danzinger RG; Richard A; Milan H; Jamieson B
Can J Hosp Pharm; 1995 Oct; 48(5):284-9. PubMed ID: 10152783
[TBL] [Abstract][Full Text] [Related]
28. Impact of the Hospital Pharmacy Initiative for promoting prudent use of antibiotics in hospitals in England.
Wickens HJ; Jacklin A
J Antimicrob Chemother; 2006 Dec; 58(6):1230-7. PubMed ID: 17030518
[TBL] [Abstract][Full Text] [Related]
29. Assuring rational antibiotic use: the impact of a joint microbiology-pharmacy surveillance program.
Plumridge RJ; McGechie DB
Aust Health Rev; 1984; 7(4):269-77. PubMed ID: 10269945
[TBL] [Abstract][Full Text] [Related]
30. Empirical use of antibiotics and adjustment of empirical antibiotic therapies in a university hospital: a prospective observational study.
Mettler J; Simcock M; Sendi P; Widmer AF; Bingisser R; Battegay M; Fluckiger U; Bassetti S
BMC Infect Dis; 2007 Mar; 7():21. PubMed ID: 17386104
[TBL] [Abstract][Full Text] [Related]
31. Effect of antibiotic order form guiding rational use of expensive drugs on cost containment.
Sirinavin S; Suvanakoot P; Sathapatayavongs B; Malatham K
Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):636-42. PubMed ID: 10437971
[TBL] [Abstract][Full Text] [Related]
32. Computer-assisted antimicrobial-use monitoring.
Inaraja MT; Paloma JM; Giráldez J; Idoate AJ; Hualde S
Am J Hosp Pharm; 1986 Mar; 43(3):664-70. PubMed ID: 3754692
[TBL] [Abstract][Full Text] [Related]
33. Effect of a targeted antibiotic advisory consult program on hospital antibiotic costs.
Murray MD; Kohler RB; Main JW
Hosp Formul; 1988 Jun; 23(6):518-24, 529-30. PubMed ID: 10287850
[TBL] [Abstract][Full Text] [Related]
34. Antibiotic streamlining: development and justification of an antibiotic streamlining program.
Ramirez JA
Pharm Pract Manag Q; 1996 Oct; 16(3):19-34. PubMed ID: 10166232
[TBL] [Abstract][Full Text] [Related]
35. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions.
Hayman JN; Sbravati EC
Am J Hosp Pharm; 1985 Jun; 42(6):1343-7. PubMed ID: 4014250
[TBL] [Abstract][Full Text] [Related]
36. A randomized, prospective evaluation of an interventional program to discontinue intravenous antibiotics at two tertiary care teaching institutions.
Bailey TC; Ritchie DJ; McMullin ST; Kahn M; Reichley RM; Casabar E; Shannon W; Dunagan WC
Pharmacotherapy; 1997; 17(2):277-81. PubMed ID: 9085319
[TBL] [Abstract][Full Text] [Related]
37. Modifying empiric antibiotic prescribing: experience with one strategy in a medical residency program.
MacCosbe PE; Gartenberg G
Hosp Formul; 1985 Sep; 20(9):986-8, 993-5, 999. PubMed ID: 10274168
[TBL] [Abstract][Full Text] [Related]
38. Cefoxitin use review.
Lazor-Bajcar JM
Can J Hosp Pharm; 1990 Oct; 43(5):221-5, xxxii. PubMed ID: 10107924
[TBL] [Abstract][Full Text] [Related]
39. Impact of an institution-specific hospital-acquired pneumonia protocol on the appropriateness of antibiotic therapy and patient outcomes.
Lancaster JW; Lawrence KR; Fong JJ; Doron SI; Garpestad E; Nasraway SA; Devlin JW
Pharmacotherapy; 2008 Jul; 28(7):852-62. PubMed ID: 18576900
[TBL] [Abstract][Full Text] [Related]
40. Medical committee enforcement of policy limiting postsurgical antibiotic use.
Nickman NA; Blissenbach HF; Herrick JD
Am J Hosp Pharm; 1984 Oct; 41(10):2053-6. PubMed ID: 6496494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
